Bluesight
PrivateLast Round
Growth Equity
Jul 17, 2023
Est. Valuation
$56.2M
Total Funding Raised
$37.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bluesight operates in Healthcare & Life Sciences and is based in Alexandria, Virginia. Its latest recorded funding round was a Growth Equity round in July 2023.
Bluesight is a healthcare technology company that provides an AI-powered medication intelligence and inventory management platform for hospitals and pharmacies.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Pharma Supply Chain, Compliance & Risk
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bluesight Comparables
Compare Bluesight with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neomend | 80% | |
| HelioMetrics | 77% | |
| Wolters Kluwer | 77% |
For institutional investors. Book with your work email.
Bluesight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jul 17, 2023 | ||||
| Series C | Jun 20, 2016 | ||||
| Series B | Jan 12, 2015 | ||||
| Series A | Jul 16, 2013 | ||||
| Seed | Oct 1, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bluesight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rock Health | Series A, Seed |
| New Leaf Venture Partners | Growth Equity, Series C, Series B, Series A |
| Monroe Capital | Growth Equity |
| Kaiser Permanente Ventures | Series C, Series B |
| Baxter Ventures | Series C |
| Black Granite Capital | Series C |
| Easton-Hunt Capital Partners, L.P. | Series A, Series C, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
Reached over 3,000 customers using their solutions.
- May 4, 2026
Reached over 2,300 customers for medication tracking solutions.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 14, 2026
Bluesight launches Prism Assistant in PrivacyPro in Virginia on Oct 14th '26, making its AI assistant for patient privacy investigations available to privacy analysts and investigators.
- attends_eventOct 4, 2026
Bluesight hosted the Patient Privacy Symposium in Virginia on Sep 30th '26, where healthcare privacy leaders discussed using artificial intelligence to identify and investigate potential privacy violations.
- hiresSep 18, 2026
Adam Rosenberg has joined Bluesight as VP of Marketing, overseeing branding through pipeline generation for a fully remote team.
For institutional investors. Book with your work email.
Bluesight Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bluesight's valuation, stock price, and market status.
Is Bluesight a public or private company?
Bluesight is a private company.
What is the current stock price of Bluesight?
Bluesight is a private company, so its shares have no public market price. Caplight tracks Bluesight's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bluesight worth (valuation)?
Bluesight's valuation is estimated at $56.2M based on funding round data.
Can I buy Bluesight stock?
Bluesight shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bluesight's last funding round?
Bluesight's most recent funding round was Growth Equity on July 17, 2023.
Who are the main investors in Bluesight?
Key investors in Bluesight include New Leaf Venture Partners, Kaiser Permanente Ventures, Baxter Ventures, Thoma Bravo.
Will Bluesight IPO soon?
No public IPO plans have been announced for Bluesight.
How can I track Bluesight secondary market activity?
Caplight tracks bids, offers, and trades in Bluesight's shares on secondary markets.